Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Apixaban Versus Dalteparin for Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Pilot Study

Siavash Piran, MDMSc,FRCPC, Michelle Zondag, BSN, RN, Drew Bednar, MD FRCSC, Brian Drew, MD FRCSC, Agnes Chmiel, MD FRCPC, Noel Chan, MBBS, MRCP, FRACP, FRCPA, John W. Eikelboom, MBBS, MSc, FRACP, FRCPA, Sam Schulman, MD PhD FRCPC

Blood (2019) 134 (Supplement_1): 2434.

https://doi.org/10.1182/blood-2019-124601

Published: 2019

Journal Articles

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

Clayton S Lewis, PhD, Marc Vasse, Professor, Patrick Van Dreden, PhD, Vladimir Y Bogdanov, PhD

Blood (2018) 132 (Supplement 1): 3784.

https://doi.org/10.1182/blood-2018-99-114906

Published: 2018

Journal Articles

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Nezam Afdhal, MD, Ajay Duggal, MD, Toshimitsu Ochiai, Tomoko Motomiya, Takeshi Kano, MSc, Tsutae Nagata, MD, Markus Peck-Radosavljevic, MD

Blood (2017) 130 (Supplement 1): 291.

https://doi.org/10.1182/blood.V130.Suppl_1.291.291

Published: 2017

Journal Articles

Alternatively Spliced Tissue Factor Levels in the Plasma of Patients with Liver Fibrosis, Liver Cirrhosis, and Hepatocellular Carcinoma: A Single-Center Retrospective Study

Nathalie Caversaccio, Raja Prince, Sara Calzavarini, PhD, Maria Desiré Reina Caro, Clayton s Lewis, Vladimir Bogdanov, PhD, Jean-Francois Dufour, Anne Angelillo-Scherrer

Blood (2017) 130 (Supplement 1): 3701.

https://doi.org/10.1182/blood.V130.Suppl_1.3701.3701

Published: 2017

Journal Articles

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Jameel Abdulrehman, MD, Rita Selby, MBBS, FRCPC, Michelle Sholzberg, MDM, MSc, FRCPC, Nydia Khargie, Erik Yeo, MD FACP, FRCPC

Blood (2017) 130 (Supplement 1): 1112.

https://doi.org/10.1182/blood.V130.Suppl_1.1112.1112

Published: 2017

Journal Articles

Comparison of Bleeding Risk between Rivaroxaban and Apixaban: a Pilot Feasibility Study

Lana A Castellucci, MD, Kerstin Hogg, Philip Chiang, Cynthia M. Wu, MD FRCPC, Genevieve Le Templier, Gregoire Le Gal, Marc Rodger, MD FRCPC

Blood (2017) 130 (Supplement 1): 1108.

https://doi.org/10.1182/blood.V130.Suppl_1.1108.1108

Published: 2017

Journal Articles

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Blood (2017) 130 (Supplement 1): 1003.

https://doi.org/10.1182/blood.V130.Suppl_1.1003.1003

Published: 2017

Journal Articles

Hypercoagulability in Cirrhotic Patients; Impact of Acquired Protein C Deficiency and Factor VIII Increase in Low Sensitivity to Thrombomodulin

Thomas Sinegre, PharmD, Cedric Duron, MD, Marc G. Berger, MD PhD, Armand Abergel, MD PhD, Aurelien Lebreton, MD PhD

Blood (2016) 128 (22): 1420.

https://doi.org/10.1182/blood.V128.22.1420.1420

Published: 2016

Journal Articles

Anticoagulation Treatment with Low Molecular-Weight Heparin for Portal Vein Thrombosis in Liver Cirrhosis: Efficacy and Risk of Hemorrhagic Complications

Jihyun Kwon, Youngil Koh, MD PhD, Jung-Hwan Yoon, Su jong Yu

Blood (2016) 128 (22): 1435.

https://doi.org/10.1182/blood.V128.22.1435.1435

Published: 2016

Journal Articles

Correlation Between Spleen Size, Thrombocytopenia and Meld Score in Chronic Liver Disease and Their Relation with Hospital Readmission

Mashrafi Ahmed, MD, Fawwad Zaidi, MD, Tahmina Begum, Ashok R. Patel, MD

Blood (2015) 126 (23): 5567.

https://doi.org/10.1182/blood.V126.23.5567.5567

Published: 2015

Journal Articles

Soluble Endothelial Protein C Receptor (sEPCR) Is Increased in Cirrhotic Patients. A Possible Role in Procoagulant Imbalance?

Thomas Sinegre, PharmD, Cedric Duron, MD, Ahmed Bouras, Arnaud Serres, Marc G Berger, MD PhD Professor, Anne-Françoise Sapin, Armand Abergel, MD PhD, Aurelien Lebreton, MD PhD

Blood (2015) 126 (23): 1080.

https://doi.org/10.1182/blood.V126.23.1080.1080

Published: 2015

Journal Articles

The Analysis of Mutual Relationship Between Hemostasis and Inflammatory Processes in Patients with Chronic Liver Diseases

Nora E. El-Bassiouni, MD PhD, Rania M. Benyamin, M.Sc., Samia H. Risk, MD PhD, Manal Y. Zahran, MD PhD, Ola M. Mahmoud, MD PhD, Raafat A. Ibrahim, MD PhD, Azza E. El Bassiouny, MD PhD

Blood (2015) 126 (23): 1015.

https://doi.org/10.1182/blood.V126.23.1015.1015

Published: 2015

Journal Articles

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

Tara L. Lin, MD, Laura F. Newell, MD, Robert K. Stuart, MD, Laura C. Michaelis, MD, Stephen E. Rubenstein, MD, Helen S. Pentikis, PhD, Timothy Callahan, PhD, Donna Alvarez, Lawrence D. Mayer, PhD, Arthur C. Louie, MD

Blood (2015) 126 (23): 2510.

https://doi.org/10.1182/blood.V126.23.2510.2510

Published: 2015

Journal Articles

Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism

Krishna Gundabolu, MD, Vijaya R. Bhatt, MD, Lori J. Maness, MD, Catalina C Amador, MD, Marco Olivera, MD, Fedja A Rochling, MD

Blood (2015) 126 (23): 4719.

https://doi.org/10.1182/blood.V126.23.4719.4719

Published: 2015

Journal Articles

Rebalanced Thrombin Generation in Liver Cirrhosis Calls for Tailored Transfusion Protocols

Romy Kremers, MSc, Marie-Claire Kleinegris, MD, Hugo ten Cate, MD PhD, Bas De Laat, MD PhD, Rob Wagenvoord, PhD, Coenraad Hemker, MD PhD

Blood (2015) 126 (23): 3523.

https://doi.org/10.1182/blood.V126.23.3523.3523

Published: 2015

Journal Articles

Factor IX Complex Linked to Disseminated Intravascular Coagulation in Patients with Cirrhosis: A Single Center Experience

Maitri Kalra, MBBS, Ashish Aggarwal, Vikas Kalra, Laura Caragol, Marwan Ghabril, Naveen Manchanda, MBBS

Blood (2015) 126 (23): 2286.

https://doi.org/10.1182/blood.V126.23.2286.2286

Published: 2015

Journal Articles

Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study

Xiao-Hui Zhang, MD, PhD, Ru Feng, Lan-ping Xu, Qian Jiang, Hao Jiang, Hai-xia Fu, Hui Liu, Ting Niu, Xin Wang, Jian-da Hu, Ming Jiang, Zhao Wang, Jing-wen Wang, Hui Ma, Yan-di Xie, Xiao-lu Zhu, Hao Wang, Lai Wei, Xiao Jun Huang

Blood (2014) 124 (21): 2778.

https://doi.org/10.1182/blood.V124.21.2778.2778

Published: 2014

Journal Articles

Resistance to Thrombomodulin but Not to Activated Protein C in Cirrhotic Patients

Thomas Sinegre, PharmD, Armand Abergel, MD PhD, Cedric Duron, MD, Marc G Berger, MD PhD Professor, Aurélien Lebreton, MD PhD

Blood (2014) 124 (21): 2839.

https://doi.org/10.1182/blood.V124.21.2839.2839

Published: 2014

Journal Articles

Infusion of DDAVP Does Not Improve Primary Hemostasis in Patients with Cirrhosis

Freeha Arshad, Sara C.M. Stoof, Frank W.G. Leebeek, Karin Ruitenbeek, Jelle Adelmeijer, Hans Blokzijl, Arie P. van den Berg, Robert J. Porte, Marieke J.H.A. Kruip, Ton Lisman

Blood (2014) 124 (21): 5044.

https://doi.org/10.1182/blood.V124.21.5044.5044

Published: 2014

Journal Articles

Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Howard Liebman, MD, Laurie Hornor, BA, Tse-Ling Fong, MD, Casey O'Connell, MD, Ilene C Weitz, MD

Blood (2013) 122 (21): 3555.

https://doi.org/10.1182/blood.V122.21.3555.3555

Published: 2013

NARROW

Apixaban Versus Dalteparin for Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Pilot Study

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Alternatively Spliced Tissue Factor Levels in the Plasma of Patients with Liver Fibrosis, Liver Cirrhosis, and Hepatocellular Carcinoma: A Single-Center Retrospective Study

Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms

Comparison of Bleeding Risk between Rivaroxaban and Apixaban: a Pilot Feasibility Study

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Hypercoagulability in Cirrhotic Patients; Impact of Acquired Protein C Deficiency and Factor VIII Increase in Low Sensitivity to Thrombomodulin

Anticoagulation Treatment with Low Molecular-Weight Heparin for Portal Vein Thrombosis in Liver Cirrhosis: Efficacy and Risk of Hemorrhagic Complications

Correlation Between Spleen Size, Thrombocytopenia and Meld Score in Chronic Liver Disease and Their Relation with Hospital Readmission

Soluble Endothelial Protein C Receptor (sEPCR) Is Increased in Cirrhotic Patients. A Possible Role in Procoagulant Imbalance?

The Analysis of Mutual Relationship Between Hemostasis and Inflammatory Processes in Patients with Chronic Liver Diseases

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism

Rebalanced Thrombin Generation in Liver Cirrhosis Calls for Tailored Transfusion Protocols

Factor IX Complex Linked to Disseminated Intravascular Coagulation in Patients with Cirrhosis: A Single Center Experience

Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study

Resistance to Thrombomodulin but Not to Activated Protein C in Cirrhotic Patients

Infusion of DDAVP Does Not Improve Primary Hemostasis in Patients with Cirrhosis

Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only